β-lactam susceptibility testing of ampicillin-susceptible non-faecalis enterococcal clinical isolates in France. (PubMed, J Antimicrob Chemother) - Jul 8, 2026 - "Overall, ampicillin may predict amoxicillin categorization for frequent non-faecalis enterococci, and with the exception of meropenem, most β-lactams may still have clinical value against these species. The different species exhibit distinct MIC distribution patterns for the tested β-lactams. Furthermore, substantial discrepancies observed between GD and BMD methods highlight the limited reliability of GD as an alternative to BMD."
Journal
|
|
; Alexandre Godmer; François Guérin; Gabriel Auger; Julie Coiffard; Marlène Amara; Vincent Cattoir
|